JAMA Psychiatry | CBD Study Published Showcases Antipsychotic …

JAMA Psychiatry

The psychiatric research journal, JAMA Psychiatry, has just published a new CBD study. The study suggests that CDB could have positive antipsychotic effects on individuals with high-risk clinical psychosis.

JAMA Psychiatry

This study builds off compelling prior research that has demonstrated CBD’s therapeutic effects. Not only does the new study shed important light on whether or not CBD has calming cognitive effects but it also showcases how it produces them. The study is named the “Effect of Cannabidiol on Medial Temporal, Mid-brain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis.”

This small study used 52 individuals. 33 of these individuals were clinical high-risk psychosis patients, and the other 19 were healthy individuals. The study was a double-blind, randomized clinical trial. A single dose of cannabidiol was given in the striatum, medial temporal cortex, and midbrain. Others received no CBD or a placebo but were

... read more at: https://potstocknews.com/jama-psychiatry-cbd-study/